Exagen Inc.
USD4.75
+0.17 (+3.71%)
CEO
John Aballi
IPO Date
2019-09-19
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Exchange
NASDAQ
Country
US
Open
$4.62
Prev. Close
$4.58
Day Low
$4.57
Day High
$4.80
52W Low
$2.59
52W High
$12.23
Market Cap
$0.11B
Volume
0.15M
| -4.9 |
| 31 Dec 2023 | FY | 56.1% | -45.1% | -104.4% | -41.6% | 1.02 | 4.02 | -1.5 |
| 31 Dec 2022 | FY | 46.9% | -104.0% | -111.6% | -55.0% | 0.83 | 7.55 | -0.9 |
| 31 Dec 2021 | FY | 57.4% | -55.6% | -31.6% | -21.8% | 0.33 | 12.10 | -6.9 |
| 31 Dec 2020 | FY | 60.6% | -39.8% | -39.9% | -21.3% | 0.64 | 8.04 | -10.0 |
| 31 Dec 2019 | FY | 53.4% | -29.8% | -21.6% | -13.6% | 0.47 | 13.78 | -26.5 |
| 31 Dec 2018 | FY | 52.6% | -24.7% | 119.0% | -27.7% | -3.67 | 2.38 | -0.1 |
| 31 Dec 2017 | FY | 47.3% | -95.6% | 552.6% | -125.7% | -4.06 | 2.66 | -0.0 |
| 31 Dec 2015 | FY | 46.9% | -106.9% | 86.5% | -131.1% | -1.17 | 0.11 | -0.1 |
| -7.0 |
| 30 Sept 2025 | Q3 | 58.4% | -41.1% | -39.1% | -11.3% | 1.55 | 4.08 | -8.9 |
| 30 Jun 2025 | Q2 | 60.4% | -25.8% | -21.1% | -7.6% | 1.20 | 4.95 | -8.3 |
| 31 Mar 2025 | Q1 | 58.9% | -24.2% | -58.6% | -9.3% | 3.66 | 2.32 | -4.4 |
| 31 Dec 2024 | Q4 | 62.1% | -27.5% | -39.4% | -8.4% | 2.41 | 2.70 | -5.0 |
| 30 Sept 2024 | Q3 | 55.8% | -40.2% | -39.1% | -11.5% | 1.83 | 4.05 | -2.8 |
| 30 Jun 2024 | Q2 | 60.1% | -19.7% | -16.9% | -6.0% | 1.36 | 4.32 | -2.8 |
| 31 Mar 2024 | Q1 | 59.6% | -23.3% | -16.8% | -6.6% | 1.17 | 4.83 | -2.1 |
| 31 Dec 2023 | Q4 | 59.2% | -40.5% | -24.6% | -9.8% | 1.02 | 4.02 | -1.6 |